Annonce • Mar 08
Nylex to Delist from Bursa Malaysia on March 11 Nylex (Malaysia) Berhad is set to be delisted from Bursa Malaysia on March 11, following the company’s failure to submit its regularisation plan on time. In a filing with Bursa Malaysia on March 6, 2025, the bourse regulator said it has dismissed the company's appeal for a further extension of six months until July 26, 2025 to submit its regularisation plan to the relevant authorities for approval. As such, Bursa Malaysia said the company would be delisted from Bursa Malaysia after two market days from March 6, that is on March 11, 2025. Upon the de-listing of the company, the company will continue to exist but as an unlisted entity. The company can still continue its operations and businesses and proceed with its corporate restructuring. Annonce • Sep 27
Nylex (Malaysia) Berhad, Annual General Meeting, Oct 29, 2024 Nylex (Malaysia) Berhad, Annual General Meeting, Oct 29, 2024, at 09:30 Singapore Standard Time. Location: no. 2a, jalan 13/2, seksyen 13, 46200 petaling jaya, selangor darul ehsan, Malaysia Annonce • Jan 31
Nylex (Malaysia) Berhad Provides Update Related to Suspension & Delisting of Securities Refer to the Nylex (Malaysia) Berhad’s announcements dated 27 January 2022 and 28 January 2022 in relation to the First Announcement and the announcements made on 16 August 2023, 23 August 2023, 13 October 2023 and 26 January 2024. Unless otherwise stated, all abbreviations and definitions used herein shall have the same meanings as those used in the said announcements. The Board announced that Bursa Securities had via its letter dated 29 January 2024 informed the Company that Bursa Securities has noted that: a) Nylex had failed to submit the proposed regularisation plan to the relevant authorities for approval within the extended timeframe of 26 January 2024 as granted by the Listing Committee via its letter dated 13 October 2023 (“LC Decision Letter”); and b) the Company has on 26 January 2024, appealed/applied for a further extension of time ("Appeal"). In the circumstances and pursuant to paragraph 8.03A(3) of the Listing Requirements and the LC Decision Letter, (i) the trading in the securities of Nylex will be suspended with effect from 7 February 2024 ("Suspension Date") even though the decision on the Appeal is still pending. (ii) However, the de-listing of the securities of the Company upon the expiry of 2 market days from the Suspension Date will be deferred pending the decision on the Appeal by Bursa Securities. New Risk • Jan 30
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: RM40.5m (US$8.55m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (RM211k revenue, or US$45k). Market cap is less than US$10m (RM40.5m market cap, or US$8.55m). Minor Risk Share price has been volatile over the past 3 months (11% average weekly change). Annonce • Sep 27
Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2023 Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2023, at 09:30 Singapore Standard Time. Location: No. 2A, Jalan 13/2, Seksyen 13,46200 Petaling Jaya Selangor Malaysia Agenda: To receive the Audited Financial Statements for the financial year ended 31 May 2023 together with the Reports of the Directors and the Auditors; To re-elect as Director, Datin Joanne Marie Lopez who is retiring pursuant to Clause 130 of the Company's Constitution; to approve the payment of Non-Executive Directors' fees for the financial year ended 31 May 2023; to approve the payment of Non-Executive Directors' fees for the financial year ending 31 May 2024, to be paid quarterly in arrears; to re-appoint Messrs BDO PLT as Auditors of the Company and to authorise the Directors to fix their remuneration and to consider other business matters. New Risk • Aug 18
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: RM44.9m (US$9.66m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 12% per year over the past 5 years. Revenue is less than US$1m (RM211k revenue, or US$45k). Market cap is less than US$10m (RM44.9m market cap, or US$9.66m). Board Change • Jan 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 5 highly experienced directors. Independent Non-Executive Director See Yan Lin was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Reported Earnings • Oct 04
Full year 2022 earnings released: RM0.007 loss per share (vs RM0.004 loss in FY 2021) Full year 2022 results: RM0.007 loss per share (further deteriorated from RM0.004 loss in FY 2021). Net loss: RM1.26m (loss widened 70% from FY 2021). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 32% per year, which means it is significantly lagging earnings. Annonce • Sep 29
Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2022 Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2022, at 09:30 Singapore Standard Time. Location: No. 2a, Jalan 13/2, Seksyen 13, 46200 Petaling Jaya Darul Ehsan Selangor Malaysia Agenda: To receive the audited financial statements for the financial year ended 31 May 2022 together with the Reports of the Directors and the Auditors thereon; to re-elect the directors who are retiring by rotation; to approve the payment of Non-Executive Directors' fees for the financial year ended 31 May 2022; to approve the payment of Directors' benefits (excluding Non-Executive Directors' fees) for the Non-Executive Directors from the date of the forthcoming AGM until the next annual general meeting of the Company; to re-appoint Messrs BDO PLT as Auditors of the Company and to authorize the Directors to fix their remuneration; to discuss proposed renewal authority for share buy-back mandate; and to discuss other matters. Reported Earnings • Jul 20
Full year 2022 earnings released: RM0.28 loss per share (vs RM0.11 profit in FY 2021) Full year 2022 results: RM0.28 loss per share (down from RM0.11 profit in FY 2021). Revenue: RM934.1m (down 19% from FY 2021). Net loss: RM50.4m (down 367% from profit in FY 2021). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has fallen by 28% per year, which means it is performing significantly worse than earnings. Reported Earnings • Apr 21
Third quarter 2022 earnings released: RM0.32 loss per share (vs RM0.028 profit in 3Q 2021) Third quarter 2022 results: RM0.32 loss per share (down from RM0.028 profit in 3Q 2021). Revenue: RM273.8m (down 5.3% from 3Q 2021). Net loss: RM57.7m (down RM62.6m from profit in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Mar 07
Investor sentiment deteriorated over the past week After last week's 16% share price decline to RM1.53, the stock trades at a trailing P/E ratio of 11.4x. Average trailing P/E is 13x in the Chemicals industry in Malaysia. Total returns to shareholders of 138% over the past three years. Upcoming Dividend • Mar 01
Inaugural dividend of RM0.39 per share Eligible shareholders must have bought the stock before 08 March 2022. Payment date: 23 March 2022. The company is not currently making a profit and is not cash flow positive. The company last paid an ordinary dividend in September 2019. The average dividend yield among industry peers is 4.3%. Annonce • Jan 27
Ancom Berhad (KLSE:ANCOM) completed the acquisition of remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX). Ancom Berhad (KLSE:ANCOM) entered into an agreement to acquire remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX) for MYR 96.7 million on July 29, 2021. Ancom Berhad (KLSE:ANCOM) submitted a formal offer to acquire remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX) for MYR 96.7 million on April 28, 2021. Out of total consideration, MYR 50 million will be paid in cash and MYR 46.7 million via the issuance of 31,129,508 new Ancom Shares at an issue price of MYR 1.50 per Ancom Share. Post completion of the Proposed Acquisition, Ancom will continue to hold 50.27% equity interest in Nylex. The Cash Consideration will be funded through a bank borrowings. Out of total consideration, Nylex to distribute an amount equivalent to MYR 164.29 million to its shareholders and retain MYR 15 million for its working capital and general corporate purposes. The Proposed Acquisition is subject to approval of the shareholders of Ancom at an extraordinary general meeting to be convened; approval of Bursa Securities for the listing and quotation of the Consideration Shares on the Main Market of Bursa Securities; approval of the shareholders of Nylex at an EGM to be convened; regulatory approvals; approval/consent from financiers/creditors of Ancom, Rhodemark and/or the Nylex Group upon the terms and subject to the conditions of the Sale of Business Agreement, where required; grant of an order of the High Court of Malaya pursuant to Section 116 of the CA 2016 and other closing conditions. As of June 28, 2021, board of Nylex (Malaysia) Berhad accepted the offer. As of August 18, 2021, on behalf of the Ancom Board, Maybank IB wishes to announce that the additional listing application in relation to the Consideration Shares to be issued pursuant to the Proposed Acquisition has been submitted to Bursa Securities. As of September 23, 2021 on behalf of the Ancom Board, Maybank IB wishes to announce that Bursa Securities had via its letter dated September 23, 2021, approved the listing of and quotation for 31,129,508 new ordinary shares in Ancom to be issued pursuant to the Proposed Acquisition, subject to, among others conditions.
The Proposal Letter shall remain valid for acceptance by the Nylex Board until 5.00 p.m. on June 28, 2021, unless extended by mutual agreement in writing and the parties are to negotiate and finalise the terms and conditions of the Sale of Business Agreement and enter into the Sale of Business Agreement within 60 days from the date of acceptance of the Proposal Letter (or such other period as the parties may agree in writing). The completion of the Proposed Acquisition shall take place at the office of Nylex on or before the date falling 90 days after the Sale of Business Agreement becomes unconditional or is deemed to have become unconditional. As of January 12, 2022, Maybank IB wishes to announce that Nylex has today, obtained the order of the High Court of Malaya confirming the special resolution passed by the shareholders of Nylex on October 26, 2021 approving the reduction of the issued share capital of Nylex and the transaction. The transaction has become unconditional.
KAF Investment Bank Berhad acted as financial advisor to Audit Committee of Ancom. Maybank Investment Bank Berhad acted as financial advisor to Ancom.
Ancom Berhad (KLSE:ANCOM) completed the acquisition of remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX) on January 26, 2022. Reported Earnings • Jan 19
Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations Second quarter 2022 results: EPS: RM0.043 (up from RM0.026 in 2Q 2021). Revenue: RM385.4m (up 46% from 2Q 2021). Net income: RM7.73m (up 72% from 2Q 2021). Profit margin: 2.0% (up from 1.7% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 31% per year and the company’s share price has also increased by 31% per year. Valuation Update With 7 Day Price Move • Dec 30
Investor sentiment improved over the past week After last week's 15% share price gain to RM1.44, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 16x in the Chemicals industry in Malaysia. Total returns to shareholders of 127% over the past three years. Annonce • Dec 10
Nylex (Malaysia) Berhad to Be Deleted from Other OTC Nylex (Malaysia) Berhad's Ordinary Shares will be deleted from other OTC effective from December 10, 2021 due to Inactive Security. Valuation Update With 7 Day Price Move • Oct 25
Investor sentiment improved over the past week After last week's 20% share price gain to RM1.42, the stock trades at a trailing P/E ratio of 13.5x. Average trailing P/E is 17x in the Chemicals industry in Malaysia. Total returns to shareholders of 134% over the past three years. Reported Earnings • Oct 04
Full year 2021 earnings released: EPS RM0.11 (vs RM0.13 loss in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM1.15b (up 1.4% from FY 2020). Net income: RM18.9m (up RM42.1m from FY 2020). Profit margin: 1.6% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance. Reported Earnings • Jul 31
Full year 2021 earnings released: EPS RM0.11 (vs RM0.13 loss in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM1.15b (up 1.4% from FY 2020). Net income: RM19.3m (up RM42.5m from FY 2020). Profit margin: 1.7% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance. Reported Earnings • Apr 29
Third quarter 2021 earnings released: EPS RM0.028 (vs RM0.021 loss in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: RM289.1m (up 5.0% from 3Q 2020). Net income: RM4.94m (up RM8.62m from 3Q 2020). Profit margin: 1.7% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 121 percentage points per year, which is a significant difference in performance. Is New 90 Day High Low • Mar 10
New 90-day high: RM0.69 The company is up 12% from its price of RM0.62 on 10 December 2020. The Malaysian market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. Reported Earnings • Jan 27
Second quarter 2021 earnings released: EPS RM0.026 (vs RM0.002 in 2Q 2020) The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: RM263.4m (down 17% from 2Q 2020). Net income: RM4.49m (up RM4.22m from 2Q 2020). Profit margin: 1.7% (up from 0.1% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 109 percentage points per year, which is a significant difference in performance. Is New 90 Day High Low • Dec 17
New 90-day high: RM0.67 The company is up 8.0% from its price of RM0.61 on 18 September 2020. The Malaysian market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 33% over the same period. Is New 90 Day High Low • Nov 02
New 90-day low: RM0.54 The company is down 24% from its price of RM0.70 on 04 August 2020. The Malaysian market is down 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period. Reported Earnings • Oct 28
First quarter earnings released Over the last 12 months the company has reported total losses of RM23.6m, with losses widening by 213% from the prior year. Total revenue was RM1.07b over the last 12 months, down 27% from the prior year. Reported Earnings • Oct 01
Full year earnings released - RM0.13 loss per share Over the last 12 months the company has reported total losses of RM23.2m, with losses widening by RM19.8m from the prior year. Total revenue was RM1.14b over the last 12 months, down 27% from the prior year. Is New 90 Day High Low • Sep 29
New 90-day low: RM0.56 The company is down 15% from its price of RM0.65 on 01 July 2020. The Malaysian market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 4.0% over the same period. 